Overview

Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to compare the efficacy and the safety of T1210 versus Olopatadine eye drops in the topical treatment of seasonal allergic conjunctivitis.

Phase:

Phase 2

Details

Lead Sponsor:

Laboratoires Thea

Treatments:

Olopatadine Hydrochloride